Non-high-density lipoprotein cholesterol: current status as cardiovascular marker

    loading  Checking for direct PDF access through Ovid


Purpose of review

In this review, we summarize the evidence with regard to the rationale of using nonhigh density lipoprotein cholesterol (non-HDL-C) as a cardiovascular disease (CVD) risk factor, in relation to low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B (apoB).

Recent findings

In the 2015 National Lipid Association Annual Summary non-HDL-C is considered a coprimary target, apart from LDL-C. The other data published in the last 18 months about non-HDL-C support all the previous published data. There are no recent findings, which we deem to cause a change of the current opinion about non-HDL-C as a predictor for CVD.


The existing evidence supports the claim that non-HDL-C is superior to LDL-C in CVD risk estimation.

Related Topics

    loading  Loading Related Articles